Ceribell (CBLL) EBIT (2023 - 2026)

Ceribell (CBLL) has reported EBIT for 4 consecutive years, with -$20.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT fell 33.63% year-over-year to -$20.0 million; the trailing twelve-month figure through Jun 2026 stood at -$70.0 million (down 34.61% YoY), and the FY2025 full-year result was -$58.4 million, down 47.07% from the prior year.
• EBIT grew to -$20.0 million in Q2 2026 per CBLL's latest filing, from -$20.7 million in the prior quarter.
• Across five years, EBIT topped out at -$7.2 million in Q3 2023 and bottomed at -$20.7 million in Q1 2026.
• Historically, EBIT has averaged -$12.9 million across 4 years, with a median of -$13.5 million in 2024.
• The widest YoY moves for EBIT: up 13.29% in 2025, down 77.26% in 2025.
• Over 4 years, EBIT stood at -$8.4 million in 2023, then sank by 53.73% to -$12.9 million in 2024, then retreated by 13.29% to -$14.6 million in 2025, then plunged by 36.89% to -$20.0 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$20.0 million, -$20.7 million, and -$14.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.